Partner Content Partner Content Featured speakers for 2nd annual Wearable Injectors and Conn... Featured speakers for 2nd annual Wearable Injectors
Partner Content Partner Content Department for International Trade to present at Wearable In... Wearable Injectors and Connected Devices Conference
Partner Content Partner Content AstraZeneca to lead a workshop during the Wearable Injectors... Wearable Injectors and Connected Devices Conference
News Andexxa reaches the end of the line in the US AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US amid reports of serious clotting side effects.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
